MedTrace Logo

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

NCT01881451 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-02-17

No results posted yet for this study

Summary

The purpose of this study is to use 18F-EF5 PET/CT scans to locate areas with low oxygen levels (hypoxia) in patients with recurrent and/or metastatic cancer.

Conditions

Interventions

DRUG

18F-EF5 PET/CT scan

Patients will undergo an investigations 18F-EF5 PET/CT scan.

PROCEDURE

Optional biopsy

Patients who choose to participate, will undergo a tissue biopsy.

Sponsors & Collaborators

  • Carraressi Foundation OVCARE

    collaborator UNKNOWN

  • British Columbia Cancer Agency

    lead OTHER

Principal Investigators

  • Anna Tinker, MD, FRCPC · British Columbia Cancer Agency

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-03-31
Completion
2020-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881451 on ClinicalTrials.gov